Literature DB >> 27006805

Crystal structure of ethyl 2-[2-(4-methyl-benzo-yl)-5-p-tolyl-1H-imidazol-1-yl]acetate.

E Arockia Jeya Yasmi Prabha1, S Suresh Kumar1, Anil K Padala2, Qazi Naveed Ahmed2, S Athimoolam1.   

Abstract

In the title compound, C22H22N2O3, the plane of the five-membered ring is oriented at dihedral angles of 45.4 (1) and 52.5 (1)° to the phenyl rings. Furthermore, this ring makes an angle of 85.2 (2)° with the plane of the ethyl acetate substituent. The mol-ecular structure is affected by an intra-molecular C-H⋯O hydrogen bond between an H atom from the p-tolyl group and the carbonyl O atom of the acetate. The methyl group of the ethyl acetate residue is disordered over two sites with equal occupancies. The crystal structure features inter-molecular C-H⋯O and C-H⋯N inter-actions. One of the C-H⋯O hydrogen bonds forms a C(5) chain motif extending along the a axis. In addition, C-H⋯N contacts form inversion dimers with R 2 (2)(12) ring motifs, linking the imidazole ring system to the benzene ring of the p-tolyl substituent.

Entities:  

Keywords:  2-(4-meth­oxy­phen­yl)-2-oxoacetaldehyde; crystal structure; glycine methyl ester hydro­chloride; imidazole derivative; new synthesis

Year:  2016        PMID: 27006805      PMCID: PMC4778819          DOI: 10.1107/S2056989016002504

Source DB:  PubMed          Journal:  Acta Crystallogr E Crystallogr Commun


Chemical context

Imidazole and its derivatives have numerous pharmaceutical applications including uses as anti­fungal (Shingalapur et al. 2009 ▸), anti­microbial (Sharma et al. 2009 ▸), anti-inflammatory (Puratchikody et al. 2007 ▸), analgesic (Achar et al. 2010 ▸), anti­tubercular (Pandey et al. 2009 ▸), anti­depressant (Hadizadeh et al. 2008 ▸), anti­leishmanial (Bhandari et al. 2009 ▸) and anti­cancer agents (Ozkay et al. 2010 ▸). We are inter­ested in the synthesis of active pharmaceutical ingredients (APIs) based on imidazoles and we report here the synthesis and crystal structure of the title imidazole derivative.

Structural commentary

The mol­ecular structure of the title compound is shown in Fig. 1 ▸. The C—N bond lengths within the imidazole ring are 1.373 (3) Å (C10—N2), 1.372 (3) Å (C8—N2), 1.349 (3) Å (C9—N1) and 1.329 (3) Å (C10—N1). These bond distances are shorter than the single-bond length (1.443 Å) and longer than the accepted double-bond length (1.269 Å) due to electron delocalization in the central imidazole ring. The phenyl rings and the plane of the imidazole ring are inclined at angles of 45.4 (1)° (with the C12–C17 ring) and 52.5 (1)° (with the C2–C7 ring). The phenyl rings are oriented to each other with a dihedral angle of 88.1 (1)°. Further, the imidazole ring is inclined at an angle of 85.2 (2)° to the best-fit plane through atoms C19, C20, O3, C21 and C22 of the ethyl acetate substituent. The mol­ecular structure is also influenced by the formation of an intra­molecular C6—H6⋯O2 hydrogen bond, Table 1 ▸, which generates an S(8) ring motif (Bernstein et al., 1995 ▸).
Figure 1

The mol­ecular structure of the title compound, showing the atom-numbering scheme and 50% probability displacement ellipsoids. The methyl group (C22) of the side chain is disordered over two positions each with 0.5 occupancy.

Table 1

Hydrogen-bond geometry (Å, °)

D—H⋯A D—HH⋯A DA D—H⋯A
C6—H6⋯O20.932.913.723 (4)147
C1—H1A⋯O2i 0.962.713.605 (4)155
C4—H4⋯N1ii 0.932.833.724 (3)161
C19—H19A⋯O2iii 0.972.513.309 (3)140

Symmetry codes: (i) ; (ii) ; (iii) .

Supra­molecular features

The N-bound methyl­ene group of the side chain is connected with the carbonyl oxygen of an adjacent mol­ecule through a C19—H19A⋯O2 hydrogen bond, forming a linear C(5) chain motif along the a axis, Table 1 ▸ and Fig. 2 ▸. The phenyl and imidazole rings are linked through inversion-dimer formation involving C4—H4⋯N1 hydrogen bonds that generate (12) ring motifs. A second inversion dimer to an adjacent mol­ecule results from C1—H1⋯O2 contacts, forming ring (22) [OK?] rings, Fig. 3 ▸.
Figure 2

Linear C(5) chains formed by a C—H⋯O inter­molecular inter­action extending along the a axis of the unit cell.

Figure 3

Inversion dimers with (12) and (22) ring motifs resulting from C—H⋯N and C—H⋯O hydrogen bonds.

Database survey

The Cambridge Structural Database (Groom & Allen, 2014 ▸) reveals only five structures of imidazole derivatives with a CH2COOCH2CH3 substituent on nitro­gen (Cai et al., 2014 ▸; Bahnous et al., 2013 ▸; Zaprutko et al., 2012 ▸). Imidazoles with benzoyl substituents are slightly more common with eight occurrences (Xue et al., 2014 ▸; Nagaraj et al., 2012 ▸; Samanta et al., 2013 ▸), while the structures of only six p-tolyl-substituted imidazoles are found (Bu et al., 1996 ▸; Fridman et al., 2006 ▸, 2009 ▸). These searches also reveal the unique nature of the mol­ecule reported here.

Synthesis and crystallization

The title compound was synthesized from a mixture of 2-(4-meth­oxy­phen­yl)-2-oxoacetaldehyde (1 mmol), glycine methyl ester hydro­chloride (1 mmol) and selenium dioxide (1 mmol) in a basic environment in aceto­nitrile at 373 K. Crystals suitable for X-ray investigation were obtained by solvent evaporation from the resulting solution in 33% yield.

Refinement

Crystal data, data collection and structure refinement details are summarized in Table 2 ▸. All H atoms were positioned geometrically and refined using a riding model, with C—H = 0.93 −0.97 Å and U iso(H) = 1.2–1.5U eq(parent C atom). The methyl group C22 of the side chain is disordered over two positions, each with a site-occupancy factor of 0.5. The atomic displacement parameters of these two C atoms are restrained to be equivalent and the C21—C22 and C21—C22′ bond distances were restrained during the refinement using DFIX commands.
Table 2

Experimental details

Crystal data
Chemical formulaC22H22N2O3
M r 362.41
Crystal system, space groupTriclinic, P
Temperature (K)293
a, b, c (Å)5.0968 (5), 13.8189 (15), 14.6993 (17)
α, β, γ (°)71.484 (5), 84.018 (5), 82.531 (5)
V3)971.20 (18)
Z 2
Radiation typeMo Kα
μ (mm−1)0.08
Crystal size (mm)0.21 × 0.19 × 0.16
 
Data collection
DiffractometerBruker SMART APEX CCD area-detector
No. of measured, independent and observed [I > 2σ(I)] reflections18453, 3405, 2354
R int 0.055
(sin θ/λ)max−1)0.595
 
Refinement
R[F 2 > 2σ(F 2)], wR(F 2), S 0.054, 0.168, 1.07
No. of reflections3405
No. of parameters251
No. of restraints2
H-atom treatmentH-atom parameters constrained
Δρmax, Δρmin (e Å−3)0.52, −0.31

Computer programs: SMART (Bruker, 2001 ▸), SAINT (Bruker, 2001 ▸), SHELXTL/PC (Sheldrick, 2008 ▸) and PLATON (Spek, 2009 ▸).

Crystal structure: contains datablock(s) I. DOI: 10.1107/S2056989016002504/sj5493sup1.cif Structure factors: contains datablock(s) I. DOI: 10.1107/S2056989016002504/sj5493Isup2.hkl Click here for additional data file. Supporting information file. DOI: 10.1107/S2056989016002504/sj5493Isup3.cml CCDC reference: 1452746 Additional supporting information: crystallographic information; 3D view; checkCIF report
C22H22N2O3Z = 2
Mr = 362.41F(000) = 384
Triclinic, P1Dx = 1.239 Mg m3
a = 5.0968 (5) ÅMo Kα radiation, λ = 0.71073 Å
b = 13.8189 (15) ÅCell parameters from 2986 reflections
c = 14.6993 (17) Åθ = 2.1–24.4°
α = 71.484 (5)°µ = 0.08 mm1
β = 84.018 (5)°T = 293 K
γ = 82.531 (5)°Block, colourless
V = 971.20 (18) Å30.21 × 0.19 × 0.16 mm
Bruker SMART APEX CCD area-detector diffractometerRint = 0.055
Radiation source: fine-focus sealed tubeθmax = 25.0°, θmin = 2.5°
ω scansh = −6→6
18453 measured reflectionsk = −16→16
3405 independent reflectionsl = −17→17
2354 reflections with I > 2σ(I)
Refinement on F22 restraints
Least-squares matrix: fullHydrogen site location: inferred from neighbouring sites
R[F2 > 2σ(F2)] = 0.054H-atom parameters constrained
wR(F2) = 0.168w = 1/[σ2(Fo2) + (0.0636P)2 + 0.5608P] where P = (Fo2 + 2Fc2)/3
S = 1.07(Δ/σ)max = 0.002
3405 reflectionsΔρmax = 0.52 e Å3
251 parametersΔρmin = −0.30 e Å3
Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and torsion angles; correlations between e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. planes.
xyzUiso*/UeqOcc. (<1)
C1−0.6633 (7)0.3819 (3)0.6826 (2)0.0754 (9)
H1A−0.61050.44760.67790.113*
H1B−0.64980.33720.74740.113*
H1C−0.84330.39010.66550.113*
C2−0.4852 (5)0.3362 (2)0.61545 (19)0.0530 (7)
C3−0.5093 (5)0.2386 (2)0.6123 (2)0.0568 (7)
H3−0.64030.20150.65170.068*
C4−0.3441 (5)0.19537 (19)0.55220 (19)0.0501 (6)
H4−0.36360.12930.55240.060*
C5−0.1486 (5)0.24912 (17)0.49132 (17)0.0426 (6)
C6−0.1244 (5)0.34725 (19)0.4938 (2)0.0536 (7)
H60.00480.38510.45390.064*
C7−0.2906 (5)0.3891 (2)0.5551 (2)0.0573 (7)
H7−0.27050.45480.55570.069*
C80.0360 (5)0.19884 (17)0.43313 (17)0.0419 (6)
C90.1875 (5)0.10614 (18)0.46091 (18)0.0466 (6)
H90.18350.06130.52330.056*
C100.2885 (5)0.16918 (17)0.31157 (17)0.0428 (6)
C110.4033 (5)0.1806 (2)0.21394 (19)0.0539 (7)
C120.6016 (5)0.0980 (2)0.19780 (17)0.0480 (6)
C170.8022 (5)0.0507 (2)0.25858 (19)0.0514 (7)
H170.81860.07170.31170.062*
C160.9772 (6)−0.0268 (2)0.2414 (2)0.0614 (8)
H161.1136−0.05600.28210.074*
C150.9556 (6)−0.0622 (2)0.1653 (2)0.0629 (8)
C140.7592 (7)−0.0130 (3)0.1034 (2)0.0777 (10)
H140.7426−0.03450.05050.093*
C130.5874 (6)0.0671 (3)0.1182 (2)0.0709 (9)
H130.46120.10040.07420.085*
C181.1384 (8)−0.1519 (3)0.1513 (3)0.0990 (13)
H18A1.0844−0.17030.09880.149*
H18B1.1306−0.20920.20890.149*
H18C1.3167−0.13340.13720.149*
C19−0.0310 (5)0.33098 (18)0.27136 (18)0.0488 (6)
H19A−0.19020.35380.30440.059*
H19B−0.08360.31500.21670.059*
C200.1464 (5)0.41606 (19)0.23635 (19)0.0510 (7)
C210.2175 (8)0.5710 (2)0.1156 (2)0.0923 (12)
H21A0.40380.54560.11980.111*
H21B0.17940.61960.15170.111*
C220.161 (3)0.6255 (15)0.0101 (4)0.119 (4)0.5
H22A0.24730.5850−0.02890.179*0.5
H22B0.22730.6915−0.01050.179*0.5
H22C−0.02670.63400.00360.179*0.5
C22'0.047 (3)0.6433 (15)0.0364 (5)0.119 (4)0.5
H22D0.00750.6068−0.00550.179*0.5
H22E0.14180.70050.00010.179*0.5
H22F−0.11560.66770.06510.179*0.5
N10.3431 (4)0.08765 (14)0.38698 (14)0.0464 (5)
N20.1006 (4)0.23871 (14)0.33651 (14)0.0434 (5)
O10.3314 (5)0.25504 (18)0.14648 (15)0.0913 (8)
O20.3358 (4)0.42182 (16)0.27496 (17)0.0774 (7)
O30.0563 (4)0.48554 (13)0.15783 (13)0.0663 (6)
U11U22U33U12U13U23
C10.077 (2)0.081 (2)0.077 (2)0.0039 (17)−0.0022 (17)−0.0423 (18)
C20.0517 (15)0.0546 (16)0.0558 (16)0.0006 (13)−0.0118 (13)−0.0211 (13)
C30.0558 (16)0.0555 (17)0.0601 (17)−0.0134 (13)0.0026 (13)−0.0185 (14)
C40.0553 (15)0.0386 (13)0.0585 (16)−0.0095 (12)−0.0050 (13)−0.0155 (12)
C50.0453 (13)0.0361 (12)0.0458 (14)−0.0031 (10)−0.0120 (11)−0.0094 (11)
C60.0531 (15)0.0392 (14)0.0681 (18)−0.0111 (12)−0.0003 (13)−0.0149 (13)
C70.0617 (17)0.0408 (14)0.0759 (19)−0.0036 (13)−0.0105 (15)−0.0259 (14)
C80.0475 (14)0.0331 (12)0.0450 (14)−0.0075 (10)−0.0073 (11)−0.0092 (11)
C90.0595 (16)0.0362 (13)0.0405 (14)−0.0052 (11)−0.0059 (12)−0.0060 (11)
C100.0459 (14)0.0346 (12)0.0447 (14)−0.0027 (10)−0.0072 (11)−0.0071 (11)
C110.0557 (16)0.0496 (15)0.0467 (15)−0.0009 (12)−0.0049 (12)−0.0025 (12)
C120.0499 (15)0.0515 (15)0.0401 (14)−0.0078 (12)−0.0016 (11)−0.0099 (11)
C170.0535 (15)0.0524 (15)0.0478 (15)−0.0058 (13)−0.0060 (12)−0.0136 (12)
C160.0600 (17)0.0582 (17)0.0561 (17)0.0031 (14)−0.0026 (13)−0.0077 (14)
C150.0662 (19)0.0526 (17)0.0669 (19)−0.0124 (14)0.0146 (15)−0.0175 (15)
C140.074 (2)0.109 (3)0.070 (2)−0.016 (2)0.0051 (17)−0.055 (2)
C130.0578 (18)0.106 (3)0.0529 (17)0.0029 (17)−0.0105 (14)−0.0325 (17)
C180.116 (3)0.063 (2)0.112 (3)−0.003 (2)0.032 (2)−0.032 (2)
C190.0471 (14)0.0397 (13)0.0500 (15)0.0019 (11)−0.0091 (11)−0.0010 (11)
C200.0540 (16)0.0381 (14)0.0522 (15)0.0030 (12)−0.0057 (13)−0.0041 (12)
C210.133 (3)0.0462 (18)0.085 (2)−0.0256 (19)−0.012 (2)0.0059 (17)
C220.199 (13)0.099 (7)0.050 (4)−0.063 (7)0.004 (6)0.004 (6)
C22'0.199 (13)0.099 (7)0.050 (4)−0.063 (7)0.004 (6)0.004 (6)
N10.0566 (13)0.0345 (11)0.0443 (12)−0.0018 (9)−0.0086 (10)−0.0061 (9)
N20.0462 (11)0.0331 (10)0.0448 (12)−0.0018 (9)−0.0081 (9)−0.0029 (9)
O10.1031 (18)0.0828 (16)0.0517 (12)0.0282 (14)0.0041 (12)0.0128 (11)
O20.0675 (13)0.0612 (13)0.0934 (16)−0.0175 (11)−0.0261 (12)0.0010 (11)
O30.0886 (14)0.0412 (10)0.0577 (12)−0.0074 (10)−0.0135 (10)0.0037 (9)
C1—C21.503 (4)C16—C151.375 (4)
C1—H1A0.9600C16—H160.9300
C1—H1B0.9600C15—C141.383 (4)
C1—H1C0.9600C15—C181.506 (4)
C2—C71.377 (4)C14—C131.379 (4)
C2—C31.386 (4)C14—H140.9300
C3—C41.377 (4)C13—H130.9300
C3—H30.9300C18—H18A0.9600
C4—C51.389 (3)C18—H18B0.9600
C4—H40.9300C18—H18C0.9600
C5—C61.390 (3)C19—N21.459 (3)
C5—C81.463 (3)C19—C201.503 (4)
C6—C71.381 (4)C19—H19A0.9700
C6—H60.9300C19—H19B0.9700
C7—H70.9300C20—O21.193 (3)
C8—C91.371 (3)C20—O31.325 (3)
C8—N21.372 (3)C21—O31.462 (4)
C9—N11.349 (3)C21—C221.534 (2)
C9—H90.9300C21—C22'1.535 (2)
C10—N11.329 (3)C21—H21A0.9700
C10—N21.373 (3)C21—H21B0.9700
C10—C111.460 (4)C22—H22A0.9600
C11—O11.227 (3)C22—H22B0.9600
C11—C121.484 (4)C22—H22C0.9600
C12—C131.379 (4)C22'—H22D0.9600
C12—C171.384 (3)C22'—H22E0.9600
C17—C161.373 (4)C22'—H22F0.9600
C17—H170.9300
C2—C1—H1A109.5C14—C15—C18121.8 (3)
C2—C1—H1B109.5C13—C14—C15121.5 (3)
H1A—C1—H1B109.5C13—C14—H14119.2
C2—C1—H1C109.5C15—C14—H14119.2
H1A—C1—H1C109.5C12—C13—C14120.4 (3)
H1B—C1—H1C109.5C12—C13—H13119.8
C7—C2—C3117.3 (3)C14—C13—H13119.8
C7—C2—C1121.5 (3)C15—C18—H18A109.5
C3—C2—C1121.2 (3)C15—C18—H18B109.5
C4—C3—C2121.6 (3)H18A—C18—H18B109.5
C4—C3—H3119.2C15—C18—H18C109.5
C2—C3—H3119.2H18A—C18—H18C109.5
C3—C4—C5120.8 (2)H18B—C18—H18C109.5
C3—C4—H4119.6N2—C19—C20111.7 (2)
C5—C4—H4119.6N2—C19—H19A109.3
C4—C5—C6117.8 (2)C20—C19—H19A109.3
C4—C5—C8119.7 (2)N2—C19—H19B109.3
C6—C5—C8122.3 (2)C20—C19—H19B109.3
C7—C6—C5120.5 (2)H19A—C19—H19B107.9
C7—C6—H6119.7O2—C20—O3124.9 (2)
C5—C6—H6119.7O2—C20—C19125.1 (2)
C2—C7—C6121.9 (2)O3—C20—C19109.9 (2)
C2—C7—H7119.1O3—C21—C22111.1 (9)
C6—C7—H7119.1O3—C21—C22'102.4 (9)
C9—C8—N2104.8 (2)O3—C21—H21A109.4
C9—C8—C5129.3 (2)C22—C21—H21A109.4
N2—C8—C5125.8 (2)O3—C21—H21B109.4
N1—C9—C8112.0 (2)C22—C21—H21B109.4
N1—C9—H9124.0H21A—C21—H21B108.0
C8—C9—H9124.0C21—C22—H22A109.5
N1—C10—N2111.2 (2)C21—C22—H22B109.5
N1—C10—C11124.2 (2)H22A—C22—H22B109.5
N2—C10—C11124.5 (2)C21—C22—H22C109.5
O1—C11—C10120.8 (2)H22A—C22—H22C109.5
O1—C11—C12120.8 (2)H22B—C22—H22C109.5
C10—C11—C12118.3 (2)C21—C22'—H22D109.5
C13—C12—C17118.2 (3)C21—C22'—H22E109.5
C13—C12—C11118.7 (2)H22D—C22'—H22E109.5
C17—C12—C11123.2 (2)C21—C22'—H22F109.5
C16—C17—C12120.8 (3)H22D—C22'—H22F109.5
C16—C17—H17119.6H22E—C22'—H22F109.5
C12—C17—H17119.6C10—N1—C9105.0 (2)
C17—C16—C15121.5 (3)C8—N2—C10106.94 (18)
C17—C16—H16119.2C8—N2—C19125.8 (2)
C15—C16—H16119.2C10—N2—C19126.8 (2)
C16—C15—C14117.4 (3)C20—O3—C21114.8 (2)
C16—C15—C18120.8 (3)
C7—C2—C3—C40.7 (4)C17—C16—C15—C143.4 (4)
C1—C2—C3—C4−178.8 (3)C17—C16—C15—C18−176.0 (3)
C2—C3—C4—C5−0.9 (4)C16—C15—C14—C13−1.4 (5)
C3—C4—C5—C60.6 (4)C18—C15—C14—C13178.0 (3)
C3—C4—C5—C8175.8 (2)C17—C12—C13—C143.8 (4)
C4—C5—C6—C70.0 (4)C11—C12—C13—C14−176.6 (3)
C8—C5—C6—C7−175.1 (2)C15—C14—C13—C12−2.3 (5)
C3—C2—C7—C6−0.2 (4)N2—C19—C20—O2−20.6 (4)
C1—C2—C7—C6179.4 (3)N2—C19—C20—O3161.4 (2)
C5—C6—C7—C2−0.2 (4)N2—C10—N1—C9−0.2 (3)
C4—C5—C8—C9−51.0 (4)C11—C10—N1—C9−177.1 (2)
C6—C5—C8—C9124.0 (3)C8—C9—N1—C10−0.3 (3)
C4—C5—C8—N2131.5 (3)C9—C8—N2—C10−0.7 (3)
C6—C5—C8—N2−53.5 (4)C5—C8—N2—C10177.3 (2)
N2—C8—C9—N10.7 (3)C9—C8—N2—C19172.2 (2)
C5—C8—C9—N1−177.2 (2)C5—C8—N2—C19−9.8 (4)
N1—C10—C11—O1175.3 (3)N1—C10—N2—C80.6 (3)
N2—C10—C11—O1−1.2 (4)C11—C10—N2—C8177.5 (2)
N1—C10—C11—C12−2.5 (4)N1—C10—N2—C19−172.3 (2)
N2—C10—C11—C12−179.0 (2)C11—C10—N2—C194.7 (4)
O1—C11—C12—C13−39.9 (4)C20—C19—N2—C8111.7 (3)
C10—C11—C12—C13137.9 (3)C20—C19—N2—C10−76.8 (3)
O1—C11—C12—C17139.7 (3)O2—C20—O3—C213.5 (4)
C10—C11—C12—C17−42.6 (4)C19—C20—O3—C21−178.5 (2)
C13—C12—C17—C16−1.8 (4)C22—C21—O3—C20160.0 (6)
C11—C12—C17—C16178.6 (2)C22'—C21—O3—C20−172.9 (6)
C12—C17—C16—C15−1.9 (4)
D—H···AD—HH···AD···AD—H···A
C6—H6···O20.932.913.723 (4)147
C1—H1A···O2i0.962.713.605 (4)155
C4—H4···N1ii0.932.833.724 (3)161
C19—H19A···O2iii0.972.513.309 (3)140
  9 in total

1.  Antinociceptive and antiinflammatory activities and QSAR studies on 2-substituted-4,5-diphenyl-1H-imidazoles.

Authors:  A Puratchikody; Mukesh Doble
Journal:  Bioorg Med Chem       Date:  2006-10-18       Impact factor: 3.641

2.  A short history of SHELX.

Authors:  George M Sheldrick
Journal:  Acta Crystallogr A       Date:  2007-12-21       Impact factor: 2.290

3.  The Cambridge Structural Database in retrospect and prospect.

Authors:  Colin R Groom; Frank H Allen
Journal:  Angew Chem Int Ed Engl       Date:  2014-01-02       Impact factor: 15.336

4.  In-vivo analgesic and anti-inflammatory activities of newly synthesized benzimidazole derivatives.

Authors:  Kavitha C S Achar; Kallappa M Hosamani; Harisha R Seetharamareddy
Journal:  Eur J Med Chem       Date:  2010-01-21       Impact factor: 6.514

5.  Synthesis, antimicrobial and antiviral evaluation of substituted imidazole derivatives.

Authors:  Deepika Sharma; Balasubramanian Narasimhan; Pradeep Kumar; Vikramjeet Judge; Rakesh Narang; Erik De Clercq; Jan Balzarini
Journal:  Eur J Med Chem       Date:  2008-09-11       Impact factor: 6.514

6.  Synthesis and antitubercular screening of imidazole derivatives.

Authors:  Jyoti Pandey; Vinod K Tiwari; Shyam S Verma; Vinita Chaturvedi; S Bhatnagar; S Sinha; A N Gaikwad; Rama P Tripathi
Journal:  Eur J Med Chem       Date:  2009-02-20       Impact factor: 6.514

7.  Synthesis, crystal structure and antibacterial activity of new highly functionalized ionic compounds based on the imidazole nucleus.

Authors:  Mebarek Bahnous; Abdelmalek Bouraiou; Meryem Chelghoum; Sofiane Bouacida; Thierry Roisnel; Farida Smati; Chafia Bentchouala; Philippe C Gros; Ali Belfaitah
Journal:  Bioorg Med Chem Lett       Date:  2013-01-11       Impact factor: 2.823

8.  Synthesis and evaluation of in vitro anti-microbial and anti-tubercular activity of 2-styryl benzimidazoles.

Authors:  Ramya V Shingalapur; Kallappa M Hosamani; Rangappa S Keri
Journal:  Eur J Med Chem       Date:  2009-05-28       Impact factor: 6.514

9.  Structure validation in chemical crystallography.

Authors:  Anthony L Spek
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-01-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.